White Cloud Mountain: Branch company obtains approval for drug supplement application.

Baiyunshan announcement, recently the Baiyunshan Pharmaceutical General Factory of the branch received the "Drug Supplementary Application Approval Notice" issued by the National Drug Administration. The approved drugs this time include Fu Ke An Pian, Kun Ling Wan, Shenxi Dan, Yigan Ling Pian, and Mai An Granule. Among them, the sales of Fu Ke An Pian in the domestic market in 2024 amounted to 27.74 million yuan, and the sales of this drug by Baiyunshan Pharmaceutical General Factory were 6.3754 million yuan. The sales of Kun Ling Wan in the domestic market in 2024 were 13.15 million yuan. The sales of Yigan Ling Pian in the domestic market in 2024 were 13.71 million yuan. The sales of Mai An Granule in the domestic market in 2024 were 9.28 million yuan.